Addiction Medicine: Closing the Gap between Science and Practice

(lu) #1

Cornelius, J. R., Bukstein, O. G., Birmaher, B., Salloum, I. M., Lynch, K., Pollock, N. K., et al. (2001).
Fluoxetine in adolescents with major depression and an alcohol use disorder: An open-label trial.
Addictive Behaviors, 26(5), 735-739.


Cornelius, J. R., Salloum, I. M., Haskett, R. F., Daley, D. C., Cornelius, M. D., Thase, M. E., et al.
(2000). Fluoxetine versus placebo in depressed alcoholics: A 1-year follow-up study. Addictive
Behaviors, 25(2), 307-310.


Cornell University Law School, Legal Information Institute. (2012). 29 USC § 1185A: Parity in Mental
Health and Substance Abuse. [Online]. from http://www.law.cornell.edu.


Cornuz, J., Zwahlen, S., Jungi, W. F., Osterwalder, J., Klingler, K., van, M. G., et al. (2008). A vaccine
against nicotine for smoking cessation: A randomized controlled trial. PLoS Medicine, 3(6), e2547.


Corrao, G., Bagnardi, V., Zambon, A., & La, V. C. (2004). A meta-analysis of alcohol consumption and
the risk of 15 diseases. Preventive Medicine, 38(5), 613-619.


Corrao, G., Rubbiati, L., Zambon, A., & Arico, S. (2002). Alcohol-attributable and alcohol-preventable
mortality in Italy. A balance in 1983 and 1996. European Journal of Public Health, 12(3), 214-223.


Correia, C. J., & Benson, T. A. (2006). The use of contingency management to reduce cigarette smoking
among college students. Experimental & Clinical Psychopharmacology, 14(2), 171-179.


Corrigan, P. W., Kuwabara, S. A., & O'Shaughnessy, J. (2009). The public stigma of mental illness and
drug addiction: Findings from a stratified random sample. Journal of Social Work, 9(2), 139-147.


Corso, P., Finkelstein, E., Miller, T., Fiebelkorn, I., & Zaloshnja, E. (2006). Incidence and lifetime costs
of injuries in the United States. Injury Prevention, 12(4), 212-218.


Costello, D. (2004). Addiction medication has a slow start in the U.S.: Many insurers, including Medi-
Cal, aren't covering the opiate substitute's cost. [Online]. Los Angeles Times. Retrieved June 4, 2012
from http://articles.latimes.com.


Costello, D., Dierker, L. C., Sledjeski, E. M., Flaherty, B., Flay, B., Shiffman, S., et al. (2007).
Confirmatory factor analysis of the Nicotine Dependence Syndrome Scale in an American college
sample of light smokers. Nicotine & Tobacco Research, 9(8), 811-819.


Cottler, L. B., Robins, L. N., & Helzer, J. E. (1989). The reliability of the CIDI-SAM: A comprehensive
substance abuse interview. British Journal of Addiction, 84(7), 801-814.


Couchenour, R. L., Carson, D. S., & Segal, A. R. (2002). Patients' views of pharmacists as providers of
smoking cessation services. Journal of the American Pharmaceutical Association, 42(3), 510-512.


Council for Accreditation of Counseling and Related Educational Programs. (2009). 2009 Standards.
[Online]. Retrieved July 16, 2009 from http://www.cacrep.org.


Council on Accreditation. (2008). About COA. [Online]. Retrieved February 14, 2012 from
http://coastandards.org.


Courtwright, D. T. (2001). Dark paradise: A history of opiate addiction in America. Cambridge, MA:
Harvard University Press.


Courtwright, D. T. (2010). The NIDA brain disease paradigm: History, resistance and spinoffs. [Online].
Retrieved December 5, 2011 from http://digitalcommons.unf.edu.


Courtwright, D. T. (2011). Language-use disorder: Comment on DSM-V's proposed 'addiction and related
disorders' and Charles O'Brien's 'Addiction and dependence in DSM-V'. Addiction, 106(5), 878-879.

Free download pdf